Metabolic-Fit / 100
Coivas review
Compounded semaglutide and tirzepatide at one price whatever your dose, which is the part worth having: $149 and $229 a month once you are past the introductory period. The numbers on the cards are lower — $119 and $199 — and those are the intro rates. Coivas is unusual in printing both on the same page rather than making you find the second one on a renewal invoice, and the ongoing figure is the one to budget against. What it does not offer is brand-name Wegovy or Zepbound, an oral option, or any mention of bloodwork, and the word "from" in front of every price is the seller telling you your dose can move it.
then $149/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Coivas at a glance
- Semaglutide
- $149/mo after the intro period, same price at every dose
- Tirzepatide
- $229/mo after the intro period, same price at every dose
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored Coivas
Every factor comes from Coivas's own published pricing, disclosures and oversight, and the six combine into the 52/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cancellation is workable but not frictionless.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- coivas.com
Prices were read from Coivas's own product cards and comparison chart in August 2026. Both the introductory rate and the ongoing one are published there: $119 rising to $149 for semaglutide, $199 rising to $229 for tirzepatide, flat at every dose. The site says dosage and titration can change what you pay, so treat those as floors rather than quotes.
What to expect when you sign up
We walked Coivas's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action leaves coivas.com for intake.coivas.com, a separate host
What we noticed
- The intake runs on Bask Health rather than on the provider's own software
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
- Intake is hosted on intake.coivas.com, so the company you fill the form in with is not the domain you started on
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $119 → $149 | All doses (flat)Card reads "From $119 · Monthly"; the comparison block gives $149 "after intro period" as the flat ongoing rate. |
| Compounded tirzepatide | $199 → $229 | All doses (flat)"From $199 · Monthly" to start, $229 ongoing, flat across the titration ladder. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Coivas's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- One price at every dose, so a titration step up does not raise the bill
- The post-intro price is published on the same page as the intro price, which is rarer than it should be
- All 50 states, and consultation, prescription, medication, shipping and ongoing support are inside the price
- Subscription is cancellable at any time per its own terms
The caveats
- The advertised $119 and $199 are introductory; ongoing is $149 and $229 — a rise of about 25% and 15%
- Every price is prefixed "from", and the site says dosage and titration can change what you pay, so no figure here is a firm quote
- No FDA-approved brand option — compounded only
- No oral or sublingual form
- Bloodwork is not mentioned anywhere, so assume it is not included
Coivas for mothers: our verdict
Compounded semaglutide and tirzepatide at one price whatever your dose, which is the part worth having: $149 and $229 a month once you are past the introductory period. The numbers on the cards are lower — $119 and $199 — and those are the intro rates. Coivas is unusual in printing both on the same page rather than making you find the second one on a renewal invoice, and the ongoing figure is the one to budget against. What it does not offer is brand-name Wegovy or Zepbound, an oral option, or any mention of bloodwork, and the word "from" in front of every price is the seller telling you your dose can move it. The advertised entry is $119, but the standing rate settles near $149/month — so read the headline as a starting offer, not the monthly cost.
We weigh Coivas the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Coivas costs, in full
- Compounded semaglutide — All doses (flat): $119 to start, then $149/mo
- Compounded tirzepatide — All doses (flat): $199 to start, then $229/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
Coivas says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Coivas prescribes
Coivas prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Coivas fits — and where it doesn't — for mothers
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Coivas is a genuine value play — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants a flat compounded price she can plan around and would rather read the post-intro number now than discover it in month two.
Alternatives to Coivas
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Coivas
Head-to-head & alternatives
Coivas, answered
- How much does Coivas cost?
- At last review, Coivas's lowest ongoing compounded rate was about $149 a month — $149/mo after the intro period, same price at every dose for semaglutide, $229/mo after the intro period, same price at every dose for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Coivas safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. Coivas is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does Coivas offer both semaglutide and tirzepatide?
- Yes — Coivas offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Coivas rank for mothers?
- Coivas scores 52/100 on our Metabolic-Fit Score and sits at #65. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect Coivas's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.